AP952A - Novel erthromycin derivatives, method for preparing same, and use thereof as drugs. - Google Patents

Novel erthromycin derivatives, method for preparing same, and use thereof as drugs. Download PDF

Info

Publication number
AP952A
AP952A APAP/P/1998/001318A AP9801318A AP952A AP 952 A AP952 A AP 952A AP 9801318 A AP9801318 A AP 9801318A AP 952 A AP952 A AP 952A
Authority
AP
ARIPO
Prior art keywords
formula
radical
compounds
methyl
dideoxy
Prior art date
Application number
APAP/P/1998/001318A
Other languages
English (en)
Other versions
AP9801318A0 (en
Inventor
Constantin Agouridas
Jean-Francis Chantot (Deceased)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AP9801318A0 publication Critical patent/AP9801318A0/xx
Application granted granted Critical
Publication of AP952A publication Critical patent/AP952A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
APAP/P/1998/001318A 1996-02-28 1997-02-27 Novel erthromycin derivatives, method for preparing same, and use thereof as drugs. AP952A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602472A FR2745290B1 (fr) 1996-02-28 1996-02-28 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
PCT/FR1997/000351 WO1997031929A1 (fr) 1996-02-28 1997-02-27 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
AP9801318A0 AP9801318A0 (en) 1998-09-30
AP952A true AP952A (en) 2001-03-29

Family

ID=9489659

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001318A AP952A (en) 1996-02-28 1997-02-27 Novel erthromycin derivatives, method for preparing same, and use thereof as drugs.

Country Status (31)

Country Link
US (1) US6096714A (ko)
EP (1) EP0885234B1 (ko)
JP (1) JP4102440B2 (ko)
KR (1) KR100486053B1 (ko)
CN (1) CN1168734C (ko)
AP (1) AP952A (ko)
AR (1) AR005999A1 (ko)
AT (1) ATE217633T1 (ko)
AU (1) AU716204B2 (ko)
BG (1) BG63207B1 (ko)
BR (1) BR9707709B1 (ko)
CZ (1) CZ293893B6 (ko)
DE (1) DE69712610T2 (ko)
DK (1) DK0885234T3 (ko)
EA (1) EA001376B1 (ko)
EE (1) EE9800265A (ko)
ES (1) ES2176698T3 (ko)
FR (1) FR2745290B1 (ko)
HU (1) HU227567B1 (ko)
IL (1) IL125622A (ko)
NO (1) NO983955L (ko)
NZ (1) NZ331600A (ko)
OA (1) OA10845A (ko)
PL (1) PL191736B1 (ko)
PT (1) PT885234E (ko)
SK (1) SK118498A3 (ko)
TR (1) TR199801713T2 (ko)
UA (1) UA58504C2 (ko)
WO (1) WO1997031929A1 (ko)
YU (1) YU37098A (ko)
ZA (1) ZA971659B (ko)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004514643A (ja) * 1997-10-29 2004-05-20 大正製薬株式会社 エリスロマイシンａ誘導体
AU9649598A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a, 11,12-carbamate derivatives
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2781484B1 (fr) 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
BR9916969A (pt) 1999-01-27 2001-11-06 Pfizer Prod Inc Antibióticos cetólidos
WO2000071557A1 (en) * 1999-05-24 2000-11-30 Pfizer Products Inc. 13-methyl-erythromycin derivatives
WO2001010880A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
AU6316400A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO2001010878A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
CA2529817C (en) 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007069264A2 (en) * 2005-12-15 2007-06-21 Alembic Limited Reference standards for determining the purity of telithromycin and processes therefor
CN101917850B (zh) 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
WO2010048599A1 (en) 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Methods for treating gastrointestinal diseases
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ，インコーポレイテッド マラリア、結核、及びｍａｃ病の治療方法
NZ602544A (en) 2010-03-22 2014-11-28 Cempra Pharmaceuticals Inc Crystalline forms of a macrolide, and uses therefor
US9051346B2 (en) 2010-05-20 2015-06-09 Cempra Pharmaceuticals, Inc. Process for preparing triazole-containing ketolide antibiotics
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
SG11201405895UA (en) 2012-03-27 2014-10-30 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
US9861616B2 (en) 2013-03-14 2018-01-09 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
JP6675973B2 (ja) 2013-03-15 2020-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド抗菌薬を調製するための集束的な方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0487411A1 (fr) * 1990-11-21 1992-05-27 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation, les nouveaux intermédiaires obtenus et leur application comme médicaments
US5444031A (en) * 1993-01-21 1995-08-22 Calgon Carbon Corporation Process for making catalytic carbon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US487411A (en) * 1892-12-06 Island
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0487411A1 (fr) * 1990-11-21 1992-05-27 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation, les nouveaux intermédiaires obtenus et leur application comme médicaments
US5444031A (en) * 1993-01-21 1995-08-22 Calgon Carbon Corporation Process for making catalytic carbon

Also Published As

Publication number Publication date
CN1168734C (zh) 2004-09-29
ZA971659B (en) 1998-02-26
IL125622A0 (en) 1999-04-11
EA199800768A1 (ru) 1999-02-25
HU227567B1 (en) 2011-08-29
CZ293893B6 (cs) 2004-08-18
AR005999A1 (es) 1999-07-21
EE9800265A (et) 1999-02-15
KR19990087324A (ko) 1999-12-27
ES2176698T3 (es) 2002-12-01
JP4102440B2 (ja) 2008-06-18
FR2745290A1 (fr) 1997-08-29
US6096714A (en) 2000-08-01
OA10845A (fr) 2003-02-05
BR9707709A (pt) 1999-04-06
HUP9902576A3 (en) 2001-03-28
DE69712610T2 (de) 2002-11-28
KR100486053B1 (ko) 2005-06-16
WO1997031929A1 (fr) 1997-09-04
EA001376B1 (ru) 2001-02-26
BG63207B1 (bg) 2001-06-29
EP0885234B1 (fr) 2002-05-15
DK0885234T3 (da) 2002-08-26
NO983955D0 (no) 1998-08-27
UA58504C2 (uk) 2003-08-15
ATE217633T1 (de) 2002-06-15
IL125622A (en) 2003-10-31
FR2745290B1 (fr) 1998-04-03
YU37098A (sh) 1999-07-28
NZ331600A (en) 1999-08-30
BG102691A (en) 1999-06-30
AP9801318A0 (en) 1998-09-30
BR9707709B1 (pt) 2014-10-14
AU1929897A (en) 1997-09-16
JP2000505469A (ja) 2000-05-09
DE69712610D1 (de) 2002-06-20
PT885234E (pt) 2002-10-31
NO983955L (no) 1998-08-27
TR199801713T2 (xx) 1998-12-21
PL191736B1 (pl) 2006-06-30
AU716204B2 (en) 2000-02-24
HUP9902576A1 (hu) 1999-12-28
CN1212700A (zh) 1999-03-31
PL328608A1 (en) 1999-02-01
SK118498A3 (en) 1999-07-12
EP0885234A1 (fr) 1998-12-23
CZ258798A3 (cs) 1998-12-16

Similar Documents

Publication Publication Date Title
AP952A (en) Novel erthromycin derivatives, method for preparing same, and use thereof as drugs.
JP3140703B2 (ja) 新規なエリスロマイシン、それらの製造法及び薬剤としての用途
AU697876B2 (en) New erythromycin derivatives, their preparation process and their use as medicaments
JP4573925B2 (ja) 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
JP5188520B2 (ja) 新規なエリスロマイシン誘導体、製造方法及び医薬としての利用
AP997A (en) Novel erythromycin derivatives, method for preparing them and their use as medicine.
AP1078A (en) Novel erythromycin derivatives, method for preparing same and use thereof as drugs.
AU728182B2 (en) New derivatives of erythromycin, their preparation process and their use as medicaments
JP4864184B2 (ja) ５−デスオサミニルエリスロノリドａの新規の２−ハロゲン化誘導体、それらの製造方法及び薬剤としてのそれらの使用
US5439890A (en) Erythromycin derivatives
USRE38520E1 (en) Erythromycin derivatives, method for preparing same, and use thereof as drugs
AU761551B2 (en) Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines
RU2144541C1 (ru) Производные эритромицина, способ их получения, промежуточный продукт, фармацевтическая композиция
MXPA99005226A (en) Novel erythromycin derivatives, method for preparing them and their use as medicine
MXPA99005840A (en) Novel erythromycin derivatives, method of preparation and application as medicines
MXPA99007812A (en) Novel erythromycin derivatives, method of preparation and application as medicines